Transient flow modulation with rapid-resorbable gelatin microspheres during Yttrium-90 radioembolization for liver cancer: a preliminary clinical trial
Authors:
Open Access
- 8 October 2026
- journal article
- interventional
- Published by Springer Nature in European Radiology
- p. 1-11
Abstract
Objectives: To explore the effectiveness of rapid-resorbable gelatin microspheres (RGMs) for protecting non-tumorous liver (NTL) through flow modulation during yttrium-90 (Y-90) radioembolization for liver cancer. Materials and methods: This phase II trial defined the primary outcome as the protection rate of RGM-embolized vs non-embolized NTL on Y-90 PET/CT. RGMs (560–800 µm) were used to transiently diminish blood flow to the NTL, followed by Y-90 microsphere administration. The effectiveness of flow modulation and radioembolization was assessed using Y-90 PET/CT and gadoxetic acid-enhanced MRI (EOB-MRI). Results: Twenty patients were enrolled between March 2023 and January 2025. The median protection rate was 35.8% (interquartile range [IQR], 20.2–66.7). Seven patients (35%, 7/20) demonstrated a ≥ 2-fold increase in the tumor-to-NTL uptake ratio on Y-90 PET/CT compared with pre-treatment SPECT/CT. The signal intensity (SI) ratio between protected and unprotected NTLs on the hepatobiliary phase of EOB-MRI increased significantly from baseline (median, 1.03; IQR, 0.97–1.05) to 6-month follow-up (median, 1.29; IQR, 1.18–1.54; p < 0.001). The Y-90 microsphere load to the NTL was negatively correlated with the protection rate ( ρ = −0.578, p = 0.010), whereas the protection rate was positively correlated with the SI ratio at 6 months ( ρ = 0.710, p = 0.001). All patients who underwent subsequent intra-arterial treatments achieved complete arterial recanalization. Conclusion: RGM-mediated flow modulation was associated with reduced Y-90 microsphere deposition in the NTL, with imaging findings suggesting regional liver function preservation. This protective effect appeared greater with lower Y-90 microsphere load. Key Points: Question Can flow modulation using RGMS preserve regional liver function ? Findings Prior embolization with rapidly resorbable gelatin microspheres reduced the absorbed dose to the NTL by 35.8% and preserved signal intensity on EOB-MRI after radioembolization . Clinical relevance RGMs can transiently divert arterial flow away from the NTL, reducing Yttrium-90 microsphere influx and helping preserve regional liver function during Yttrium-90 radioembolization for liver cancer .Keywords
Funding Information
- Nextbiomedical
This publication has 20 references indexed in Scilit:
- Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working groupEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluationEuropean Radiology, 2022
- International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheresEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposureEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapyCancer Immunology, Immunotherapy, 2018
- Prophylactic Temporary Occlusion of the Cystic Artery Using a Fibered Detachable Coil During 90Y RadioembolizationCardioVascular and Interventional Radiology, 2017
- Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCCJournal of Hepatology, 2016
- RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working GroupEuropean Journal of Cancer, 2016
- Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 TeslaEuropean Radiology, 2014
- Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013